Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats
Drospirenone (DRSP) is a progestin with anti-aldosterone properties and it reduces blood pressure in hypertensive women. However, the effects of DRSP on endothelium-dependent coronary vasodilation have not been evaluated. This study investigated the effects of combined therapy with estrogen (E2) and...
Main Authors: | M.V. Borgo, E.R.G. Claudio, F.B. Silva, W.G. Romero, S.A. Gouvea, M.R. Moysés, R.L. Santos, S.A. Almeida, P.L. Podratz, J.B. Graceli, G.R. Abreu |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2016-01-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000100601&lng=en&tlng=en |
Similar Items
-
Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review
by: Sebastián Carranza-Lira
Published: (2008-12-01) -
Validated HPTLC method for simultaneous estimation of ethinyl estradiol and drospirenone in bulk drug and formulation
by: Bhusari Vidhya K., et al.
Published: (2012-06-01) -
Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study
by: Li Li, et al.
Published: (2020-02-01) -
The efficacy of 17β-estradiol and low dosed drospirenone use in postmenopausal women (literature review)
by: E N Andreeva, et al.
Published: (2015-02-01) -
Efficacy and safety of ultralow doses of drospirenone and 17β-estradiol in postmenopausal women meta-analysis
by: O. R. Grigoryan
Published: (2018-04-01)